Wikipedia -WSS

Wikipedia

author：hotspot 2025-08-23 08:57:31 - browse：924

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients.

The group of independent experts voted 9-3 that the benefits of Alnylam’s drug, called patisiran, outweighed its risks for patients with ATTR-CM, a progressive disease that leads to fatal heart failure if left untreated. The FDA, which is not required to follow the advice of advisers, is expected to make a final decision on patisiran by Oct. 8.

“It’s like a light wind blowing in favor of patisiran over placebo,” said David Cella, a neurologist at the Northwestern University Feinberg School of Medicine who voted in favor of patisiran. David Moliterno, a cardiologist at the University of Kentucky, added that “the good news in this story is that while there may be a small benefit, it doesn’t look like there’s a signal for harm.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Pregnancy discrimination could be enabled by AI

WSS

Climate activists disrupt London Pride march to protest corporate sponsorship

FDA needs staff influx to meet gene therapy needs, Marks says

Scientists find bacteria from stomach of ancient iceman

Does Medicare's free annual wellness visit do any good?

The woman behind the Dana Farber

Calls for Trump's election interference trial to be televised part of long debate

leisure time

Wikipedia

focus

Sports medicine is finally prioritizing gender equality

In diabetes hearing, Sanders takes on a new foe: food makers

New air purifier tech could be key to improving indoor air quality

Congenital heart disease patients face new threat of heart failure

What does generative AI mean for health care? We asked experts

After sickle

Medicare proposal to cover medical devices draws a mixed reaction

Slain Parkland victim's father speaks out following reenactment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Russian court extends detention of American musician

focus

Patients' immediate access to test results puts radiologists in a bind

Scientists find bacteria from stomach of ancient iceman

After sickle

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

FDA approves world's first CRISPR

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

focus

knowledge

focus

entertainment